source
- Marrow Therapeutics secures $173 million to advance siRNA therapy for sickle cell, targeting CRISPR competitionMarrow Therapeutics announced a $173 million financing round to fund development of its siRNA drug aimed at treating sickle cell disease. The funding comes after FDA approval of two gene therapies…
- Heidi Overton faces Senate committee vote on FDA commissioner nomination amid uncertaintyThe Trump administration’s nominee for FDA commissioner, Heidi Overton, is scheduled for a vote before the Senate health, education, labor and pensions committee. Lawmakers have not indicated a cl…